Skin permeation rate as a function of chemical structure

Journal of Medicinal Chemistry

Volumn 49, Issue 11, 2006, Pages 3305-3314

  Katritzky, Alan R ^a   Dobchev, Dimitar A ^a,f   Fara, Dan C ^a   Hür, Evrim ^a   Tämm, Kaido ^a   Kurunczi, Ludovic ^b   Karelson, Mati ^c   Varnek, Alexandre ^d   Solov'ev, Vitaly P ^e  

^a University of Florida   (United States)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c TALLINN UNIVERSITY OF TECHNOLOGY   (Estonia)

^d UMR 7509 du CNRS   (France)

^e RUSSIAN ACADEMY OF SCIENCES   (Russian Federation)

^f UNIVERSITY OF TARTU   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOBARBITAL; ANTIHISTAMINIC AGENT; ANTINEOPLASTIC AGENT; ATROPINE; BARBITAL; BUTETHAL; CHLORPHENIRAMINE; CODEINE; CORTICOSTEROID; CORTICOSTERONE; CORTISONE; CORTODOXONE; DEOXYCORTICOSTERONE; DEXAMETHASONE; DICLOFENAC; DIGITOXIN; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE; FLUOROURACIL; GLYCERYL TRINITRATE; HYDROCORTISONE; INDOMETACIN; METHOXSALEN; NICOTINE; NONSTEROID ANTIINFLAMMATORY AGENT; PSORALEN DERIVATIVE; UNINDEXED DRUG;

ARTICLE; ARTIFICIAL NEURAL NETWORK; CALCULATION; CHEMICAL STRUCTURE; HYDROPHOBICITY; MATHEMATICAL MODEL; PARTITION COEFFICIENT; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SKIN PERMEABILITY;

COMPUTER SIMULATION; LINEAR MODELS; MOLECULAR STRUCTURE; NEURAL NETWORKS (COMPUTER); PERMEABILITY; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; REGRESSION ANALYSIS; SKIN; SKIN ABSORPTION;

EID: 33744824393     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm051031d     Document Type: Article

References (50)

1. Fujii, M.; Takeda, Y.; Yoshida, M.; Utoguchi, N.; Matsumoto, M.; Watanabe, Y. Comparison of skin permeation enhancement by 3-1-menthoxypropane-1, 2-diol and 1-menthol: the permeation of indomethacin and antipyrine through yucatan micropig skin and changes in infrared spectra and X-ray diffraction patterns of stratum corneum. Int. J. Pharm. 2003, 258, 217-223.
2. Tanojo, H.; Boelsma, E.; Junginger, H. E.; Ponec, M.; Bodde, H. E. In vivo human skin permeability enhancement by oleic acid: a laser doppler velocimetry study. J. Controlled Release. 1999, 58, 97-104.
3. Patel, H.; Berge, W.; Cronin, M. T. D. Quantitative structure-activity relationships (QSARs) for the prediction of skin permeation of exogenous chemicals. Chemosphere 2002, 48, 603-613.
4. Schaefer, H.; Redelmeier, T. E. Skin barrier: Principles of Percutaneoes Absorption; S. Karger, Ed.; Zurich, Switzerland, 1996.
5. Schnetz, E.; Fartasch, M. Microdialysis for the evaluation of penetration through the human skin barrier - a promising tool for future research? Eur J. Pharm. Sci. 2002, 12, 165-174.
6. Tang, H.; Blankschtein, D.; Langer, R. Effects of low-Frequency ultrasound on the transdermal permeation of mannitol: comparative studies with in vivo and in vitro skin. J. Pharm. Sci. 2002, 91, 1776-1794.
7. Cronin, M. T. D.; Dearden, J. C.; Gupta, R.; Moss, G. P. An investigation of the mechanism of flux Across polydimethylsiloxane membranes by use of quantitative structure-permeability relationships, J. Pharm. Pharmacol. 1999, 50, 143-152.
8. Franz, J. T. Percutaneous absorption on the relevance of in vitro data. J. Invest. Dermatol. 1975, 64, 190-195.
9. Bronaugh, R. L.; Stewart, R. F.; Congdon, E. R.; Giles, A. L. Methods for in vitro percutaneous absorption studies. I. Comparison with in vivo results. Toxicol. Appl. Pharmacol. 1982, 62, 474-480.
10. Barry, B. W. Dermatological formulations. Percutaneous absorption. (Drugs and the pharmaceutical sciences); Marcel Dekker: New York, 1983.
11. Bronaugh, R. L.; Maibach, H. I. Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in the human and monkey. J. Invest. Dermatol. 1985, 84, 180-183.
12. Friend, D. R In vitro skin permeation techniques. J. Controlled Release. 1992, 18, 235-248.
13. Bartek, M. J.; LaBudde, J. A.; Maibach, H. I. Skin permeability in vivo. Comparison in rat, rabbit, pig and man. J. Invest. Dermatol. 1972, 58, 114-123.
14. Chow, C.; Chow, A. Y. K.; Downie, R. H. H. S Buttar, Percutaneous absorption of hexachlorophene in rats, guinea pigs and pigs. Toxicology 1978, 9, 147-154.
15. Bronaugh, R. L.; Stewart, R. F.; Congdon, E. R. Methods for in vitro percutaneous absorption studies. II. Animal models for human skin. Toxicol. Appl. Pharmacol. 1982, 62, 481-488.
16. Itoh, T.; Xia, J.; Magavi, R.; Nishihata, T.; Rytting, J. H. Use of shed snake skin as a model membrane for in vitro percutaneous penetration studies: Comparison with human skin. Pharm. Res. 1990, 7, 1042-1047.
17. Lin, S. Y.; Hou, S. J.; Hsu, T. H.; Yeh, F. L. Comparisons of different animal skins with human skin in drug percutaneous penetration studies. Methods Find. Exp. Clin. Pharmacol. 1992, 14, 645-654.
18. Harada, K.; Murakami, T.; Kawasaki, E.; Higashi, Y.; Yamamoto, S.; Yata, N. In-vitro permeability to salicylic acid of human, rodent, and shed snake skin. J. Pharm. Pharmacol. 1993, 45, 414-418.
19. Patel, H.; Cronin, M. Determination of the optimal physicochemical parameters to use in a QSAR-approach to predict skin permeation rate, Final Report CEFIC-LRI Project No. NMALRI-A2.2UNJM-0007, June 2001.
20. Pugh, W. J.; Degim, I. T.; Hadgraft, J. Epidermal permeability-penetrant structure relationships: QSAR of permeant diffusion across human stratum corneum in terms of molecular weight, H-bonding and electronic charge. Int. J. Pharm. 2000, 197, 203-211.
21. Scheuplein, R. J.; Blank, I. H. Permeability of the skin. Physiol. Rev. 1971, 51, 702-747.
22. Lien, E. J.; Tong, G. L. Physicochemical properties and percutaneous absorption of drugs. J. Soc. Cosmet. Chem. 1973, 24, 371-384.
23. Roberts, M. S.; Anderson, R. A.; Swarbrick, J. Permeability of human epidermis to phenolic compounds. J. Pharm. Pharmacol. 1977, 29, 677-683.
24. Flynn, G. L. Physicochemical determinants of skin absorption. In Principles of route-to-route exptrapolation for risk assessment; Gerrity, T. R., and Henry, C. J., Eds.; Elsevier: New York, 1990.
25. Moss, G. P.; Dearden, J. C.; Patel, H.; Cronin, M. T. D. Quantitative structure-permeability relationships (QSPRs) for percutaneous absorption. Toxicol. in Vitro 2002, 16, 299-317.
26. ISIDA, May 2005. http://infochim.u-strasbg.fr/recherche/isida/index.php (accessed May 2005).
27. Wilschut, A.; ten Berge, W.; Robinson, P. J.; McKone, T. Estimating skin permeation. The validation of five mathematical skin permeation models. Chemosphere 1995, 30, 1275-1296.
28. Johnson, M.; Blankschtein, D.; Langer, R. Evaluation of solute permeation through the stratum corneum: lateral bilayer diffusion as the primary transport mechanism. J. Pharm. Sci. 1997, 86, 1162-1172.
29. Raevsky, O. A.; Schaper, K.-J. Quantitative estimation of hydrogen bond to permeability and absorption processes of some chemicals and drugs. Eur. J. Med. Chem. 1998, 33, 799-807.
30. Nakai, J. S.; Stathopulos, P.; Campbell, G.; Chu, I.; Li-Muller, A.; Aucoin, R. Penetration of chloroform, trichloroethylene, and tetrachloroethylene through human skin. J. Tox. Environ. Health 1999, 58, 157-170.
31. Buchwald, P.; Bodor, N. A simple, predictive, structure-based skin permeability model. J. Pharm. Pharmacol. 2001, 53, 1087-1098.
32. Xu, X.; Mariano, T. M.; Laskin, J. D.; Weisel, C. P. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicol. Appl. Pharmacol. 2002, 184, 19-26.
33. Kwon, K. H.; Kim, K. I.; Jun, W. J.; Shin, D. H.; Cho, H. Y.; Hong, B. S. In vitro and in vivo effects, of macrophage-stimulatory polysaccharide from leaves of perilla frutescens var. crispa. Biol. Pharm. Bull. 2002, 25, 367-371.
34. Plessis, J.; Pugh, W. J.; Judefiend, A.; Hadgraft, J. Physico-chemical determinants of dermal drug delivery: effects of the number and substitution pattern of polar groups. Eur. J. Pharm. Sci. 2002, 16, 107-112.
35. Abraham, M. H.; Martins, F. Human skin permeation and partition: general linear free-energy relationship analyses. J. Pharmacol. Sci. 2004, 93, 1508-1523.
36. Diez Sales, O.; Castellano, A. L.; Lacer, F. J. M.; Dominiquez, M. H. An in vitro percutaneous absorption study of nonionic compounds across human skin. Pharmazie 1993, 48, 684-686.
37. Interactive Analysis LogP and LogW Predictors, May 2005. http://www.logp.com/ (accessed May 2005).
38. Syracuse Research Corporation, September 2004. http://esc.syrres.com/ interkow/kowdemo.htm (accessed May 2005).
39. Daylight Chemical Information Systems, Inc May 2005. http://www.daylight. com/release/f_manuals.html (accessed - May 2005).
40. Mdl Information Systems, Inc., May 2005. http://mdl.com (accessed May 2005).
41. Hypercube, Inc., May 2005. http://www.hyper.com (accessed May 2005).
42. Stewart, J. J. P. MOPAC 7.0, QCPE #455.
43. CODESSA PRO, May 2005. http://www.codessa-pro.com (accessed May 205).
44. Karelson, M. Molecular Descriptors in QSAR/QSPR; Wiley-Interscience: New York, 2000.
45. Benson, S. W.; Buss, J. H. Additivity rules for estimation of thermo chemical properties. J. Chem. Phys. 1958, 29, 546-572.
46. Haykin, S. Neural Networks. A Comprehensive Foundation, Pearson Education Inc, 1999.
47. Stone, M. An asymptotic equivalence of choice of model by cross-validation and Akaike's criterion. J. R. Stat. Soc. 1977, 38, 44-47.
48. Dobchev, D. A.; Karelson, M. Reparametrized Austin Model for the Quantitative - Property Relationships in Liquid Media. J. Mol. Model. 2006, 12, 503-512.
49. Solov'ev, V. P.; Varnek, A Anti-HIV Activity of HEPT, TIBO and Cyclic Urea Derivatives: Structure-Property Studies, Focused Combinatorial Library Generation and Hits Selection Using Sub-structural Molecular Fragments Method. J. Chem. Inf. Comput. Sci. 2003, 45, 1703-1719.
50. Varnek, A.; Fourches, D.; Solov'ev, V. P.; Baulin, V. E.; Turanov, A. N.; Karandashev, V. K.; Fara, D.; Katritzky, A. R. "In Silico" Design of New Uranyl Extradants Based on Phosphoryl-Containing Podands: QSPR Studies, Generation and Screening of Virtual Combinatorial Library and Experimental Tests. J. Chem. Inf. Comput. Sci. 2004, 44, 1365-1382.